Technology News and Research

RSS

Preclinical study results of AVL-181 protease inhibitor presented

Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.

5 Oct 2009

New consumer At-Home Skin Typing and Analysis Kit unveiled

Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit.

5 Oct 2009

BronxRHIO to deploy Axolotl's health information exchange solutions

The Bronx Regional Health Information Organization today announced that it has signed an agreement with Axolotl Corp., the nationwide leader in health information exchange (HIE) solutions and services. The BronxRHIO, a not-for-profit organization established by the borough’s leading healthcare organizations, will deploy Axolotl’s Elysium® Exchange suite of solutions to enable healthcare providers to securely access and share clinical information, with a goal of reducing healthcare costs and improving the quality of patient care.

5 Oct 2009

Baptist Healthcare System deploys Mckesson's Horizon Enterprise Revenue Management solution

Kentucky-based Baptist Healthcare System plans to stay ahead of the information technology curve. When a switch was flipped on Aug. 15 at Baptist Hospital Northeast in La Grange, Ky., the health system became the first to simultaneously implement both the access and business management modules of McKesson’s Horizon Enterprise Revenue Management™ solution.

5 Oct 2009

Prednisporin is a key asset in the proposed acquisition of Fovea by Sanofi-Aventis

CombinatoRx, Incorporated, today announced that its ophthalmic collaborator, Fovea Pharmaceuticals SA, has entered into a proposed acquisition with Sanofi-Aventis. A CombinatoRx-derived combination drug candidate, Prednisporin, (FOV1101), which is a fixed dose combination of prednisolone and cyclosporine, is the most advanced product asset in the Fovea pipeline, with Phase 2b clinical studies planned for the treatment of persistent allergic conjunctivitis.

5 Oct 2009

Biochemics signs research collaboration agreement with Unilever

BioChemics, Inc. a company “enhancing drug delivery through biophysical modulation,” is pleased to announce the signing of a research collaboration agreement with Unilever, one of the world’s largest consumer goods companies, to utilize BioChemics’ proprietary topical delivery technology for the delivery of Unilever’s compounds.

5 Oct 2009

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

Sigma-Aldrich Corporation and Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA binding protein (ZFP)-modified cell lines for commercial production of protein pharmaceuticals.

5 Oct 2009

ImThera Medical launches the aura6000 neurostimulation system for treating Obstructive Sleep Apnea

Today, at the American Academy of Otolaryngology-Head and Neck Surgery annual meeting, ImThera Medical, Inc. unveiled its new product, the aura6000™ neurostimulation system for the treatment of Obstructive Sleep Apnea (OSA).

5 Oct 2009

New technique for tracing ultra-fine particles

Limit values for fine dust emissions are based on total particle weight. It is the ultra-fine particles, however, that are particularly harmful to health. A new technique separates them by size and identifies their composition - directly where they arise.

5 Oct 2009

Jefferies expands its global Healthcare Investment Banking Group

Jefferies today announced the expansion of its global Healthcare Investment Banking Group with the hiring of five senior professionals. Henry Elphick, Tommy Erdei and Probir Rao join as Managing Directors, Gil Bar-Nahum as a Senior Vice President, and Andrew Clayton as a Vice President. Henry Elphick, Tommy Erdei and Gil Bar-Nahum are based in London, Probir Rao is based in Mumbai, and Andrew Clayton in Hong Kong.

5 Oct 2009

Positive results from Depomed's Phase 3 clinical trial of DM-1796 for postherpetic neuralgia

Depomed, Inc. today announced top-line results from a Phase 3 clinical trial demonstrating DM-1796 (also referred to as gabapentin ER) achieved a statistically significant reduction in pain associated with postherpetic neuralgia (PHN) versus placebo using the baseline observation carried forward (BOCF) method required by FDA.

5 Oct 2009

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

Theraclone Sciences, Inc., a Seattle-based biotechnology company, and Zenyaku Kogyo Co., Ltd., a pharmaceutical company based in Tokyo, today announced that they have entered into a multi-year research and development agreement.

5 Oct 2009

Lupin grants Salix exclusive rights to its bioadhesive drug delivery technology for use with rifaximin

Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin’s proprietary technology.

5 Oct 2009

Oral Cancer Foundation initiates program to donate VELscope screening systems

The Oral Cancer Foundation recently initiated a program of donating VELscope® Oral Cancer Screening Systems to free clinics and others located in, and helping communities with, underserved populations.

5 Oct 2009

New distributor program from A-Life Medical

A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding (CAC) products and services to the healthcare industry, announced today that A-Life Hospital, its wholly owned subsidiary, introduced a new distributor program, A-Life Partners.

5 Oct 2009

Former President Clinton awards certification for new clean water system

The first chlorination system designed for cities in poor countries is now operating in Port-au-Prince, Haiti, announced Andrew Weiss at the Clinton Global Initiative (CGI) meeting in New York last week. "It's a great success," said Weiss.

5 Oct 2009

NHIT achieves milestone with NHIN CONNECTfx gateway software

Nationwide Health Information Technology, Inc. (NHIT) today announced the milestone of 4,000 production transactions processed through the NHIN using CONNECTfx based on the U.S. Government's open-source CONNECT solution.

5 Oct 2009

Intensive care units not designed for end-of-life care

Almost half of the patients who die in intensive care units die within 24 hours, but the environment is not equipped to provide good end-of-life care. Most relatives are nevertheless happy with the care given, shows a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

5 Oct 2009

Registry to help patients in need of bone marrow transplants

Nearly 70 percent of patients needing a marrow transplant do not have a matching donor in their family, leaving minorities particularly vulnerable to finding a donor who can provide a perfect match of common tissue types, according to Be the Match®, a movement that engages the public to help patients in need of bone marrow or umbilical cord blood transplants.

5 Oct 2009

Hansen Medical to exhibit its Lynx Robotic Ablation Catheter at the workshop on Cardiac Arrhythmias

Hansen Medical, Inc. will showcase its new Lynx Robotic Ablation Catheter for the first time at Venice Arrhythmias 2009, the 11th International Workshop on Cardiac Arrhythmias, Oct. 4-7, in Venice, Italy. The Lynx catheter is a small, flexible irrigated ablation catheter for customers in Europe to offer stability during the treatment of Atrial Fibrillation (AF).

5 Oct 2009

Technology News and Research

Preclinical study results of AVL-181 protease inhibitor presented

New consumer At-Home Skin Typing and Analysis Kit unveiled

BronxRHIO to deploy Axolotl's health information exchange solutions

Baptist Healthcare System deploys Mckesson's Horizon Enterprise Revenue Management solution

Prednisporin is a key asset in the proposed acquisition of Fovea by Sanofi-Aventis

Biochemics signs research collaboration agreement with Unilever

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

ImThera Medical launches the aura6000 neurostimulation system for treating Obstructive Sleep Apnea

New technique for tracing ultra-fine particles

Jefferies expands its global Healthcare Investment Banking Group

Positive results from Depomed's Phase 3 clinical trial of DM-1796 for postherpetic neuralgia

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

Lupin grants Salix exclusive rights to its bioadhesive drug delivery technology for use with rifaximin

Oral Cancer Foundation initiates program to donate VELscope screening systems

New distributor program from A-Life Medical

Former President Clinton awards certification for new clean water system

NHIT achieves milestone with NHIN CONNECTfx gateway software

Intensive care units not designed for end-of-life care

Registry to help patients in need of bone marrow transplants

Hansen Medical to exhibit its Lynx Robotic Ablation Catheter at the workshop on Cardiac Arrhythmias

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News